FDA Inspection 1283814 — Nanhai Beisha Pharmaceutical Co., Ltd.
The FDA completed an inspection of Nanhai Beisha Pharmaceutical Co., Ltd. on Sep 19, 2025 in Nanhai, Foshan. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Veterinary.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 19, 2025
- Fiscal Year
- 2025
- Product Type
- Veterinary
- Project Area
- Monitoring of Marketed Animal Drugs, Feed, and Devices
- Location
- Nanhai, Foshan (China)